Loading company…
ProFibrix develops products and services for hemostasis and regenerative pharmaceuticals.
Founded in 2004 in the Netherlands, ProFibrix is a biotechnology company serving the hemostasis and regenerative pharmaceutical markets.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in